Stereotaxis (STXS) news
Recent news
Stereotaxis Q2 recurring revenue USD 6.2 million
AInvest Wire · Aug 11, 2026Stereotaxis - files for resale of 108.87 mln shares of common stock by selling stockholders - SEC filing
Stereotaxis, Inc. (NYSE: STXS) has filed with the U.S. Securities and Exchange Commission (SEC) for the resale of up to 108.87 million shares of its common stock by selling stockholders, according to a recent SEC filing. The company did not indicate that it would receive any proceeds from the…
AInvest Wire · Jul 15, 2026Stereotaxis closes purchase of Robocath
Stereotaxis (NYSE: STXS) has completed the acquisition of Robocath, a French-based developer of robotic technologies for interventional cardiology and neurointerventions, as previously announced in April 2026 . The transaction, valued at $20 million upfront with additional contingent payments of up…
AInvest Wire · Jul 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.